The discovery and development of P2 receptor subtypes.
Extracellular purine and pyrimidine nucleotides modulate cellular activity by acting at P2 receptors. The first receptor to be identified was the P(2)-purinoceptor, which was characterised and named in 1978. In the 1980s this site was subdivided into P(2X) and P(2Y) purinoceptors on the basis of pharmacological criteria in functional studies on native receptors. Subsequently, a similar approach led to the characterisation of the P(2T), P(2Z), P(2U) and P(2D) purinoceptors. In the 1990s a molecular biological approach has led to the cloning and functional expression of at least 12 mammalian P2 receptor subtypes. The challenge now is to relate these recombinant receptors to native receptors present within a wide range of tissues.
Kennedy
C
C
Department of Physiology and Pharmacology, Strathclyde Institute of Biomedical Research, University of Strathclyde, 27 Taylor Street, G4 0NR, Glasgow, UK. c.kennedy@strath.ac.uk
D000818:Animals; D006801:Humans; D008024:Ligands; D018048:Receptors, Purinergic P2 / Q000096:biosynthesis / Q000737:chemistry / Q000187:drug effects* / Q000235:genetics
D008024:Ligands; D018048:Receptors, Purinergic P2